Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Gene Editing, CRISPR Therapy

Jennifer Doudna

PhD

🏢University of California, Berkeley🌐USA

Professor of Chemistry and Molecular and Cell Biology; Executive Director of the Innovative Genomics Institute

155
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jennifer Doudna shared the 2020 Nobel Prize in Chemistry for her co-discovery of CRISPR-Cas9 as a programmable tool for genome editing. Her laboratory at UC Berkeley and the Innovative Genomics Institute develops CRISPR applications for cancer, genetic disease, and agriculture. She has co-founded multiple therapeutic companies translating CRISPR into clinical cancer treatments.

Share:

🧪Research Fields 研究领域

CRISPR-Cas9
genome editing
RNA biology
cancer gene therapy
therapeutic CRISPR

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jennifer Doudna 的研究动态

Follow Jennifer Doudna's research updates

留下邮箱,当我们发布与 Jennifer Doudna(University of California, Berkeley)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment